Serine Proteinase Inhibitor (Serpin) E1 As an Early Urine Biomarker of Subclinical Renal Fibrosis in Children with Transplant Associated Thrombotic Microangiopathy (TA-TMA) | Synapse
March 3, 2026
Serine Proteinase Inhibitor (Serpin) E1 As an Early Urine Biomarker of Subclinical Renal Fibrosis in Children with Transplant Associated Thrombotic Microangiopathy (TA-TMA)
Key Points
Serpin E1 levels significantly correlate with renal fibrosis in affected children, indicating potential for early diagnosis.
The study found elevated serpin E1 in urine, linking it with subclinical renal changes.
Assessment using urine biomarker levels reveals insights into the progression of TA-TMA-related complications.
Identifying serpin E1 could lead to timely interventions in children with transplant-associated conditions.
Like
Bookmark
Share
Like
Bookmark
Share
Cite This Study
McCormack-Spivey et al. (Sun,) studied this question.